Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
Phase I trial of SNS-314, a novel selective inhibitor of Aurora kinases A, B, and C, in advanced solid tumor patients Robert, F., Hurwitz, H., Uronis, H., Verschraegen, C., Advani, R., Chen, A., Messerschmidt, G. L., Havrilla, N., Taverna, P., Evanchik, M. PERGAMON-ELSEVIER SCIENCE LTD. 2008: 91–92
View details for DOI 10.1016/S1359-6349(08)72217-1
View details for Web of Science ID 000261221200282